1887
Preview this article:
Zoom in
Zoomout

Increased vancomycin minimum inhibitory concentration among isolates in Malaysia, Page 1 of 1

| /docserver/preview/fulltext/jmm/59/12/1530-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.022079-0
2010-12-01
2019-10-15
Loading full text...

Full text loading...

/deliver/fulltext/jmm/59/12/1530.html?itemId=/content/journal/jmm/10.1099/jmm.0.022079-0&mimeType=html&fmt=ahah

References

  1. CLSI ( 2006; ). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard, 7th edn, M7-A7, vol. 26 no. 2. Wayne, PA: Clinical and Laboratory Standards Institute.
  2. CLSI ( 2009; ). Performance Standards for Antimicrobial Susceptibility Testing; 19th Informational Supplement. M100-S19, vol. 29 no. 3. Wayne, PA: Clinical and Laboratory Standards Institute.
  3. Hidayat, L. K., Hsu, D. I., Quist, R., Shriner, K. A. & Wong-Beringer, A. ( 2006; ). High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med 166, 2138–2144.[CrossRef]
    [Google Scholar]
  4. Ho, P. L., Lo, P. Y., Chow, K. H., Lau, E. H., Lai, E. L., Cheng, V. C. & Kao, R. Y. ( 2010; ). Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong. J Infect 60, 140–145.[CrossRef]
    [Google Scholar]
  5. Hsu, D. I., Hidayat, L. K., Quist, R., Hindler, J., Karslsson, A., Yusof, A. & Wong-Beringer, A. ( 2008; ). Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of methicillin-resistant Staphylococcus aureus (MRSA) infections. Int J Antimicrob Agents 32, 378–385.[CrossRef]
    [Google Scholar]
  6. Liu, C. & Chambers, H. F. ( 2003; ). Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother 47, 3040–3045.[CrossRef]
    [Google Scholar]
  7. Lodise, T. P., Graves, J., Evans, A., Graffunder, E., Helmecke, M., Lomaestro, B. M. & Stellrecht, K. ( 2008; ). Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteraemia treated with vancomycin. Antimicrob Agents Chemother 52, 3315–3320.[CrossRef]
    [Google Scholar]
  8. Ministry of Health ( 2008; ). National Surveillance of Antibiotic Resistance Report. Malaysia: Ministry of Health. http://www.imr.gov.my/report/nsar.htm.
  9. Moise, P. A. & Schentag, J. J. ( 2000; ). Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections. Int J Antimicrob Agents 16, S31–S34.
    [Google Scholar]
  10. Moise, P. A., Smyth, D. A., El-Fawal, N., Robinson, D. A., Holden, P. N., Forrest, A. & Sakoulas, G. ( 2008; ). Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 61, 85–90.
    [Google Scholar]
  11. Norazah, A., Salbiah, N., Nurizzat, M. & Santhana, R. ( 2009; ). Vancomycin treatment failure in a vancomycin susceptible methicillin-resistant Staphylococcus aureus (MRSA) infected patient. Med J Malaysia 64, 166–167.
    [Google Scholar]
  12. Prakash, V., Lewis, J. S. & Jorgensen, J. H. ( 2008; ). Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used. Antimicrob Agents Chemother 52, 4528.[CrossRef]
    [Google Scholar]
  13. Robert, J., Bismuth, R. & Jarlier, V. ( 2006; ). Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20 year study in a large French teaching hospital, 1983–2002. J Antimicrob Chemother 57, 506–510.[CrossRef]
    [Google Scholar]
  14. Sader, H. S., Rhomberg, P. R. & Jones, R. N. ( 2009; ). Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 53, 3162–3165.[CrossRef]
    [Google Scholar]
  15. Sakoulas, G., Moise-Broder, P. A., Schentag, J., Forest, A., Moellering, R. C. & Eliopoulos, G. M. ( 2004; ). Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteraemia. J Clin Microbiol 42, 2398–2402.[CrossRef]
    [Google Scholar]
  16. Soriano, A., Marco, F., Martinez, J. A., Pisos, E., Almela, M., Dimova, V. P., Alamo, D., Ortega, M., Lopez, J. & Mensa, J. ( 2008; ). Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteraemia. Clin Infect Dis 46, 193–200.[CrossRef]
    [Google Scholar]
  17. Steinkraus, G., White, R. & Friedrich, L. ( 2007; ). Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001–05. J Antimicrob Chemother 60, 788–794.[CrossRef]
    [Google Scholar]
  18. Walsh, T. R., Bolmström, A., Qwärnström, A., Ho, P., Wootton, M., Howe, R. A., MacGowan, A. P. & Diekema, D. ( 2001; ). Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol 39, 2439–2444.[CrossRef]
    [Google Scholar]
  19. Wang, G., Hindler, J. F., Ward, K. W. & Bruckner, D. A. ( 2006; ). Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol 44, 3883–3886.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.022079-0
Loading
/content/journal/jmm/10.1099/jmm.0.022079-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error